COMPANY DATA
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical…
PRICE HISTORY
1D
+0.2 %
1W
+9.9 %
1M
+19 %
6M
+84.9 %
YTD
+71.8 %
1Y
+128.3 %
2Y
+72.8 %
5Y
-50.1 %
10Y
+34.7 %
EARNINGS
Next earnings date
29/10/2026 (in 64 days)
Volatility around earnings
~53% stronger price swings than usual
PATTERN CHART
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 20/08/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
SCORES
Valued significantly more expensively than its own historical average.
Very strong uptrend.
Average balance sheet quality.
Not enough data yet for an assessment.
Weak growth or expensive relative to it.
Insiders are selling more shares than they buy.
Roughly meets expectations.
More upgrades than downgrades from analysts recently.
Very negative social media sentiment, swinging strongly.
Persistently high short volume ratio, partly with a Reg SHO threshold listing.
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 26/08/2026.
ASK THE AGENTS ABOUT ILMN
ANALYST ASSESSMENT
PRICE TARGET LOW
US$155.00
CONSENSUS
US$200.14
MEDIAN
US$210.00
PRICE TARGET HIGH
US$230.00
1
STRONG BUY
25
BUY
18
HOLD
6
SELL
0
STRONG SELL
50
TOTAL · Buy
| DATE | ANALYST FIRM | RATING | ACTION |
|---|---|---|---|
| 03/08/2026 | Piper Sandler | Overweight | maintain |
| 03/08/2026 | Citigroup | Sell | maintain |
| 03/08/2026 | Canaccord Genuity | Hold | maintain |
| 31/07/2026 | Stifel | Buy | maintain |
| 31/07/2026 | TD Cowen | Hold | maintain |
| 31/07/2026 | RBC Capital | Outperform | maintain |
| 31/07/2026 | Barclays | Underweight | maintain |
| 31/07/2026 | JP Morgan | Overweight | maintain |
METRICS
P/E
41.78
P/B
12.03
EV/EBITDA
26.18
RETURN ON EQUITY
7.3 %
NET MARGIN
17.9 %
DEBT/EQUITY
0.89
DIVIDEND YIELD
0 %
AS OF
28/06/2026
FREE FLOAT & LIQUIDITY
FREE FLOAT
97.6 %
FLOAT SHARES
147,736,890
AVG. DAILY VOLUME (30D)
1,849,011
INSIDER TRANSACTIONS (SEC)
| DATE | INSIDER | ROLE | TRANSACTION | SHARES | PRICE | PLAN TYPE |
|---|---|---|---|---|---|---|
| 21/08/2026 | Meister Keith A. | Director | Sale | 13,050 | 212.65 | Spontaneous |
| 21/08/2026 | Meister Keith A. | Director | Sale | 8,187 | 217.84 | Spontaneous |
| 21/08/2026 | Meister Keith A. | Director | Sale | 15,263 | 216.88 | Spontaneous |
| 21/08/2026 | Meister Keith A. | Director | Sale | 7,151 | 211.54 | Spontaneous |
| 21/08/2026 | Meister Keith A. | Director | Sale | 3,883 | 220.13 | Spontaneous |
INSTITUTIONAL HOLDERS
| FUND / INSTITUTION | SHARES | CHANGE | AS OF |
|---|---|---|---|
| BlackRock, Inc. | 19,191,398 | +167,808 | 30/06/2026 |
| Capital World Investors | 15,425,298 | -124,662 | 30/06/2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,627,157 | -196,497 | 30/06/2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,587,534 | -7,302 | 30/06/2026 |
| STATE STREET CORP | 6,507,288 | +77,944 | 30/06/2026 |
STOCK SPLITS
| DATE | RATIO |
|---|---|
| 23/09/2008 | 2:1 |
Smart Money
Zum Guru-Radar →Not investment advice. Past performance is not an indicator of future results.